IT1216570B - Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione. - Google Patents

Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.

Info

Publication number
IT1216570B
IT1216570B IT8820145A IT2014588A IT1216570B IT 1216570 B IT1216570 B IT 1216570B IT 8820145 A IT8820145 A IT 8820145A IT 2014588 A IT2014588 A IT 2014588A IT 1216570 B IT1216570 B IT 1216570B
Authority
IT
Italy
Prior art keywords
procedure
preparation
pharmaceutical composition
controlled release
release pharmaceutical
Prior art date
Application number
IT8820145A
Other languages
English (en)
Other versions
IT8820145A0 (it
Inventor
Maria Lucia Lovrecich
Original Assignee
Vectorpharma Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vectorpharma Int filed Critical Vectorpharma Int
Priority to IT8820145A priority Critical patent/IT1216570B/it
Publication of IT8820145A0 publication Critical patent/IT8820145A0/it
Priority to US07/276,489 priority patent/US5008114A/en
Priority to AT88120153T priority patent/ATE77547T1/de
Priority to EP88120153A priority patent/EP0336014B1/en
Priority to ES88120153T priority patent/ES2042700T3/es
Priority to DE8888120153T priority patent/DE3872382T2/de
Application granted granted Critical
Publication of IT1216570B publication Critical patent/IT1216570B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition
IT8820145A 1988-04-08 1988-04-08 Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione. IT1216570B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT8820145A IT1216570B (it) 1988-04-08 1988-04-08 Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
US07/276,489 US5008114A (en) 1988-04-08 1988-11-28 Pharmaceutical compositions with controlled release, and a method for their preparation
AT88120153T ATE77547T1 (de) 1988-04-08 1988-12-02 Pharmazeutische zusammensetzungen mit verlaengerter wirkung und verfahren zu ihrer herstellung.
EP88120153A EP0336014B1 (en) 1988-04-08 1988-12-02 Pharmaceutical compositions with controlled release, and a method for their preparation
ES88120153T ES2042700T3 (es) 1988-04-08 1988-12-02 Composiciones farmaceuticas con liberacion controlada, y metodo para su preparacion.
DE8888120153T DE3872382T2 (de) 1988-04-08 1988-12-02 Pharmazeutische zusammensetzungen mit verlaengerter wirkung und verfahren zu ihrer herstellung.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8820145A IT1216570B (it) 1988-04-08 1988-04-08 Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.

Publications (2)

Publication Number Publication Date
IT8820145A0 IT8820145A0 (it) 1988-04-08
IT1216570B true IT1216570B (it) 1990-03-08

Family

ID=11164167

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8820145A IT1216570B (it) 1988-04-08 1988-04-08 Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.

Country Status (6)

Country Link
US (1) US5008114A (it)
EP (1) EP0336014B1 (it)
AT (1) ATE77547T1 (it)
DE (1) DE3872382T2 (it)
ES (1) ES2042700T3 (it)
IT (1) IT1216570B (it)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290570A (en) * 1989-05-30 1994-03-01 Purepac, Inc. Lotions containing liquid-loaded powder
FR2694701B1 (fr) * 1990-04-18 1996-01-19 Biagianti Irene Application des zeolithes naturelles a l'homme et a l'environnement.
IT1243745B (it) * 1990-10-17 1994-06-21 Vectorpharma Int Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione.
US5225204A (en) * 1991-11-05 1993-07-06 Chen Jivn Ren Stable dosage of levothyroxine sodium and process of production
US5409903A (en) * 1992-02-18 1995-04-25 Urecap Corporation Method and compositions for the treatment of H. pylori and dermatitis
US5298261A (en) * 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
WO1994007469A1 (en) * 1992-09-25 1994-04-14 Dynagen, Inc. An immunobooster for delayed release of immunogen
ES2077547T3 (es) * 1992-11-17 2000-06-16 Yoshitomi Pharmaceutical Microesfera de liberacion sostenida que contiene un antipsicotico y procedimiento de produccion.
NZ262562A (en) * 1993-02-23 1996-04-26 Warner Lambert Co Preparation of solvent free pharmaceutical compositions
HU219487B (hu) * 1993-11-19 2001-04-28 Janssen Pharmaceutica Nv. Riszperidont tartalmazó mikrorészecskék, eljárás előállításukra, alkalmazásuk és ezeket tartalmazó gyógyászati készítmények és előállításuk
DE4416001C2 (de) * 1994-05-06 1997-12-11 Feinchemie Gmbh Sebnitz Komposite zur steuerbaren Wirkstoff-Freisetzung
EP0810853B1 (en) * 1995-02-24 2004-08-25 Elan Pharma International Limited Aerosols containing nanoparticle dispersions
EE03758B1 (et) * 1996-05-29 2002-06-17 Orion Corporation Lahustuvad oksiidid bioloogiliseks kasutamiseks
US6764690B2 (en) 1996-05-29 2004-07-20 Delsitech Oy Dissolvable oxides for biological applications
US7101575B2 (en) 1998-03-19 2006-09-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
HUP0200277A3 (en) * 1999-02-22 2004-03-29 Bioxid Oy Biodegradable ceramic fibres from silica sols
GB9904485D0 (en) * 1999-02-27 1999-04-21 Procter & Gamble Method for protecting and/or controlled release of active ingredient
DE60000622T2 (de) * 1999-06-10 2003-02-27 Max Planck Gesellschaft Einkapselung von kristallen mit mehrschichtigem überzug
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
EP1269994A3 (en) * 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmaceutical compositions comprising drug and concentration-enhancing polymers
PL367674A1 (en) * 2001-06-22 2005-03-07 Pfizer Products Inc. Pharmaceutical compositions of adsorbates of amorphous drug
JP2005523262A (ja) * 2002-02-01 2005-08-04 ファイザー・プロダクツ・インク 薬物及び親油性ミクロ相形成物質の非晶質分散物の医薬組成物
US20040132771A1 (en) * 2002-12-20 2004-07-08 Pfizer Inc Compositions of choleseteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors
ATE540671T1 (de) 2003-08-04 2012-01-15 Bend Res Inc Pharmazeutische zusammensetzungen von adsorbaten von amorphen arzneimitteln und lipophilen mikrophasen-bildenden materialien
US7387793B2 (en) 2003-11-14 2008-06-17 Eurand, Inc. Modified release dosage forms of skeletal muscle relaxants
MY142989A (en) * 2004-03-10 2011-02-14 Bayer Schering Pharma Ag Stabilised supersaturated solids of lipophilic drugs
DE102004013637A1 (de) 2004-03-19 2005-10-13 Capsulution Nanoscience Ag Verfahren zur Herstellung von CS-Partikeln und Mikrokapseln unter Verwendung poröser Template sowie CS-Partikel und Mikrokapseln
FI20070174A0 (fi) * 2007-02-28 2007-02-28 Delsitech Oy Menetelmä silikakoostumusten valmistamiseksi, silikakoostumukset ja niiden käytöt
ITMI20071930A1 (it) * 2007-10-05 2009-04-06 Sasol Italy S P A Composizioni farmaceutiche a base di zeoliti porose quali mezzi di rilascio di molecole farmacologicamente attive e relativo uso
BRPI1009121A2 (pt) 2009-03-04 2018-06-19 Orexo Ab formulações resistentes a abuso
KR101830080B1 (ko) 2009-05-08 2018-02-21 엠플리큐어 아베 지오폴리머성 결합제를 포함하는 지속형 약물 전달 조성물
DK2613784T3 (da) 2010-09-07 2018-01-29 Emplicure Ab Indretning til transdermal indgivelse af lægemiddel
WO2013096596A1 (en) * 2011-12-20 2013-06-27 Latham Keith R Sustained drug release and improved product stability using non-covalent particle coating methods
EP2919903B1 (en) 2012-11-14 2020-07-22 W.R. Grace & CO. - CONN. Compositions containing a biologically active material and a non-ordered inorganic oxide
CN106456548A (zh) * 2014-03-31 2017-02-22 麻省理工学院 包括含药物活性物质化合物的多孔材料
GB201502073D0 (en) 2015-02-09 2015-03-25 Cubic Pharmaceuticals Ltd And Delta Pharmaceuticals Ltd HDEG technology

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923969A (en) * 1973-06-12 1975-12-02 Battelle Institut E V Carrier system for a drug with sustained release
US4013785A (en) * 1975-03-21 1977-03-22 Bristol-Myers Company Apap tablet containing fumed silica and process for manufacturing same
DE2845326C2 (de) * 1978-10-18 1985-05-23 Beiersdorf Ag, 2000 Hamburg Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
US4834978A (en) * 1984-10-01 1989-05-30 Biotek, Inc. Method of transdermal drug delivery
GB8606468D0 (en) * 1986-03-15 1986-04-23 Sds Biotech Uk Ltd Therapeutic compositions
US4775535A (en) * 1986-04-04 1988-10-04 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
JPS6327502A (ja) * 1986-07-22 1988-02-05 Agency Of Ind Science & Technol シクロデキストリン−シリカ複合体及びその製造方法

Also Published As

Publication number Publication date
DE3872382D1 (de) 1992-07-30
EP0336014B1 (en) 1992-06-24
US5008114A (en) 1991-04-16
IT8820145A0 (it) 1988-04-08
EP0336014A1 (en) 1989-10-11
ATE77547T1 (de) 1992-07-15
ES2042700T3 (es) 1993-12-16
DE3872382T2 (de) 1992-12-10

Similar Documents

Publication Publication Date Title
IT1216570B (it) Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
DE68909139T2 (de) Substanz FR901228 und deren Herstellung.
KR890007739A (ko) 안정화된 의약물질, 이의 제조방법, 및 안정한 의약제제
CA2009890A1 (en) Valproic acid
IL83031A0 (en) 13beta-milbemycin derivatives,their preparation and their use as pesticides
NO901306L (no) N-(3-hydroksy-4-piperidinyl)(dihydrobenzofuran, dihydro-2h-benzopyran eller dihydrobenzodioksin)-karboksamidderivater.
SE8102194L (sv) Terapeutiskt aktiv organisk forening och farmaceutisk beredning innehallande denna
MX9304627A (es) Composiciones de amifostina cristalina y metodos para la preparacion y el uso de las mismas.
DE68919010D1 (de) Purinverbindungen, Verfahren zu ihrer Herstellung und pharmazeutische Präparate.
LV10270A (lv) 2-[(2-Piridinil)metilsulfinil-(vai sulfonil)]-1H-benzimidazol-1-ila atvasinajumi to iegusanas panemiens farmaceitiska kompozicija uz to bazes pielietojums
PT83572B (pt) Processo para a preparacao de compostos heterociclicos de quinoxalina e de composicoes farmaceuticas que os contem
EP0091726A3 (en) 5-substituted 1,2,4-oxadiazole derivatives, their preparation and pharmaceutical compositions containing them
IT1224405B (it) Composti attivi sul sistema cardiovascolare
NO870560D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
ES2053946T3 (es) Un procedimiento para la preparacion de tetrahidroimidazo(1,4)benzodiazepin-2-onas.
DK78487A (da) Farmaceutisk praeparat indeholdende et i vand kvaeldende polymermateriale
NO903430L (no) Fremgangsmaate for fremstilling av aminoketonderivater.
DE3676491D1 (de) Gelatinekapseln mit gesteuerter wirkstofffreisetzung und verfahren zur herstellung derselben.
NO883520D0 (no) Fremgangsmaate for fremstilling av et injeksjonspreparat.
ES2051731T3 (es) Un procedimiento para preparar antibioticos macrolidos y su uso.
HUT47020A (en) Process for production of stabilly injectable medical compounds containing as active substance 1,4-dihidroxi-5,8-bis/2/2-hidroxi-ethil-amin/-ethil-amin-antraquinon-dihydrochlorid
MY101266A (en) Pharmaceutical formulations
ES2018186B3 (es) Preparacion de himecromona de alta resorcion y procedimiento para su obtencion.
KR870010872A (ko) 루프성 이뇨제의 경피 치료 시스템용 조성물의 제조방법
JPS6456617A (en) Sustained release antipsychotic agent